Professor Dame Sally Davies is the Special Envoy on Antimicrobial Resistance for the United Kingdom. Prior to this role, Dame Sally was the Chief Medical Officer for England and Chief Medical Adviser to the UK government from March 2011 to September 2019, having held the post on an interim basis since June 2010. She shares her motivation for joining the Council and raising awareness for global health.

From your perspective, why is engagement and awareness raising for global health important?

We need the public to start driving action. On antimicrobial resistance (AMR), public engagement does not currently match the scale of the threat, and this will directly impact our ability to change behaviours and policies,. Everyone has a role – leadership can come from the top, as well as from grass-roots, so we need to work together.

How are you committed to engaging in global health topics within your current professional role and activities?

As UK Special Envoy on AMR, I engage bilaterally and multilaterally to raise awareness and drive action on AMR. In 2021, I advised the UK’s G7 Presidency to secure bold commitments on AMR, and I am now honoured to be a Member of  the UN Global Leaders Group on AMR to accelerate action across all sectors. I co-lead the UK’s Investor Action on AMR initiative to galvanise the voices and influence of investors to support antibiotic sustainability. In my role as Master of Trinity College, I founded and launched The Trinity Challenge, a global initiative to use data to better respond to global health emergencies.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

I hope to collaborate with other members to share expertise and best practice, and inspire collaboration across sectors and countries on global health. Our collective network will hopefully be able to find new ways and new platforms of engaging; I also hope to inspire young people to follow in the footsteps of Virchow Prize winners.

Victor J. Dzau, MD is the President of the National Academy of Medicine (NAM) in the United States. In addition, he serves as Vice Chair of the National Research Council. Dr Dzau is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital (BWH), as well as Chairman of the Department of Medicine and Director of the Falk Cardiovascular Research Center at Stanford University. As a member of the Virchow Foundation for Global Health Council, Dr Dzau is motivated to help honour special achievements in global health towards elevating visibility of the field.

From your perspective, why is engagement and awareness raising for global health important?

Advancing global health requires collective action. Health threats, such as infectious disease crises, do not respect national borders. There is a need to respond effectively to global health threats – both urgent crises and ongoing health challenges. In addition, there is a rising challenge of increasing rates of NCDs and endemic infections (e.g., TB, HIV/AIDS).

Achieving global health and well-being is an important part of the United Nations Sustainable Development Goals (UN SDGs). Individuals and governments have an important role to play. Stakeholders and decision-makers must act to promote the common good and renew their commitment to multilateralism and the multilateral system. Community engagement and trust is vital. Citizens can protect one another and demonstrate social and moral responsibility by acting in the best interests of all.

How are you committed to engaging in global health topics within your current professional role and activities?

From my childhood experience and life journey, beginning in post-war China, advancing global health and equity has always been a passion and commitment of mine.

Throughout my career, I have been active in numerous efforts to advance global health, including the founding of the Harvard BWH Division of Global Health Equity, the International Partnership in Innovation in Healthcare, the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation, and the founding of the Coalition for Epidemic Preparedness and Innovation.

In my current professional role, I engage in global health efforts in a number of ways, both in my capacity as President of the NAM and in my individual capacity. In both roles, I help shape and advise policies and initiatives that advance health globally.

At the National Academies, I helped design and launch the initiatives on Global Health Risk Framework; Global Health and Future Role of the US; Crossing the Global Quality Chasm and Human Genome Editing. I led the NAM’s response to COVID-19, which includes numerous committees, reports, consultations and communication on a range of issues including public health, vaccine allocation, health equity and mental health.

I have engaged with the global response to COVD-19 by providing leadership as a member of the Global Preparedness Monitoring Board, Co-chair of the G20 Scientific Expert Panel on Global Health Security, Advisor to the G20 High Level Independent Panel on Financing and a principal of the ACT-Accelerator which includes COVAX, the global collaboration for accelerating the development, manufacture and equitable distribution of COVID-19 vaccines.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

I look forward to serving with my esteemed colleagues on the Virchow Foundation for Global Health Council to contribute to the improvement of health worldwide. The Council offers an important platform to work across sectors and regions to elevate global health and raise the visibility of the field. Furthermore, the Council oversees the Virchow Prize for Global Health which offers an important opportunity to recognize the special merits and achievements in the field of global health. The Prize is important to the field, since there is arguably no global health award or prize on the scale of other scientific and medical prizes, such as the Nobel Prize or the Lasker Awards. As a member of the Council, I look forward to championing this important effort.

Dr Hajjeh is a senior public health leader with 25 years of experience in global health, health policy and diplomacy, and health management, especially in the Middle East Region. Since 2019, Dr Hajjeh serves as the Director of Programme Management at the World Health Organization Eastern Mediterranean Regional Office (WHO/EMRO). Prior to this role, she held the position of the Director of the Department of Communicable Diseases Prevention and Control. Prior to joining WHO/EMRO in 2016, Dr Hajjeh worked with the United States Centers for Disease Prevention and Control for 23 years. Dr Hajjeh is motivated to join the Council to bring more visibility to global health priorities.

From your perspective, why is engagement and awareness raising for global health important?

It is critical to get more commitment from all key stakeholders including governments, partners, people and communities. With Covid-19 in particular, but for many other important cross cutting public health issues, such as infectious diseases and environmental health, it has become very clear that “no one is safe until everyone is safe”. Better awareness of global health issues will be critical to ensure more support at all levels for the important issues that affect us all, more resources and capacity building, and more accountability. 

How are you committed to engaging in global health topics within your current professional role and activities?

As part of my role as senior WHO official, and as overseeing all technical health issues in the region, I am responsible for ensuring we focus on implementing the many global health strategies, closely monitoring and seeing results at country level. I am also engaged in the development of many of these policies, supporting countries, and advocating for the importance of stronger global health systems and platforms.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

In my role with the foundation, I would like to bring more awareness of global health priorities from the WHO overall and especially regional perspectives, and a better sense of real challenges on the ground, as well as what is currently done and being achieved, so we don’t duplicate efforts. I think the Virchow prize will bring important visibility to global health and hopefully motivate further achievements in this area as well.

From your perspective, why is engagement and awareness raising for global health important?

It is essential because we are and live in an interconnected world. The COVID-19 pandemic amplified that even further. The global community once more realised that “no one is safe until everyone is safe.”

Health is a human right, and we must work together collectively to ensure this – “Health For All” – for all people.

How are you committed to engaging in global health topics within your current professional role and activities?<

Ever since I started my academic and professional career, I am passionate about and committed to the global health landscape. All my work is therefore connected to it, pushing for accelerated action to reach health equity driven by human rights. Of particular relevance to this is probably my work with the World Health Organization (WHO) and the World Health Summit, further raising awareness for the determinants of health and global health.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

Reflecting on the decade of working together with Detlev Ganten, Co-Founder of the Virchow Foundation for Global Health, it is truly amazing to see the idea of this Prize come to life. I am proud to have been an active contributor from the beginning and am very happy to see it come to fruition. The Virchow Prize for Global Health itself, but even more so the laureate and her or his work, will be able to make global health tangible for many more people.

In 1980, Elizabeth Macintyre graduated in Medicine from the Newcastle-Upon-Tyne University in the United Kingdom, where she also trained in internal medice. She then specialised in clinical/laboratory haematology at University College London, obtained her PhD at St. Louis Hospital in Paris, France and completed her postdoctoral period at Harvard University. Since 1992, she has been a professor in Diagnostic Haematology at the Université Paris Cité and Necker-Enfants-Malades Hospital, where she also co-directs an INSERM/CNRS research team on normal and pathological lymphoid development at the Institut Necker-Enfants-Malades (INEM). Professor Macintyre currently serves as President of the European Hematology Association (EHA) and is President-Elect of the Biomedical Alliance in Europe.

Dr. John-Arne Røttingen, MD, PhD, MSc, MPA, is currently Ambassador for Global Health at the Ministry of Foreign Affairs of Norway. He received his MD and PhD from the University of Oslo, an MSc from Oxford University and an MPA from Harvard, where he is adjunct professor at the Department of Global Health and Population at Harvard T.H. Chan School of Public Health. In addition, he is Adjunct Scientific Director at the Norwegian Institute of Public Health and Visiting Fellow of Practice at Blavatnik School of Government, Oxford University, and was the founding interim Chief Executive Officer of CEPI (Coalition for Epidemic Preparedness Innovations). Prior to his role in the Ministry of Foreign Affairs, he was the Chief Executive of the Research Council of Norway; Executive Director of Infection Control and Environmental Health at the Norwegian Institute of Public Health; Professor of Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo. He has been the founding Chief Executive of the Norwegian Knowledge Centre for Health Services; Oxford Scholar at Wadham College; Fulbright Fellow at Harvard Kennedy School; Chair of the Board of the Alliance for Health Policy and Systems Research; and Chair of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), WHO (World Health Organization). As a member of the Virchow Foundation Council, Ambassador Røttingen is motivated to help contribute to a broader visibility and understanding of global health amongst the public.